世界の凝固因子市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Clotting Factor Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1391
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、凝固因子のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（凝固因子I、凝固因子II、凝固因子III、凝固因子IV、その他）、用途別市場規模（病院、クリニック、外来手術センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・凝固因子の市場動向
・企業の競争状況、市場シェア
・凝固因子の種類別市場規模（凝固因子I、凝固因子II、凝固因子III、凝固因子IV、その他）
・凝固因子の用途別市場規模（病院、クリニック、外来手術センター）
・凝固因子の北米市場規模2016-2027（アメリカ、カナダ）
・凝固因子のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・凝固因子のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・凝固因子の中南米市場規模2016-2027（メキシコ、ブラジル）
・凝固因子の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Amgen、Novartis、Baxter、Britannia、Capricor、CSL Behring、GlaxoSmithKline、Grifol、Eli Lilly）
・結論

Coagulation factors are various protein components involved in blood coagulation. Its physiological function is to be activated when blood vessels bleed, stick to platelets and plug leaks in blood vessels.

Market Analysis and Insights: Global Clotting Factor Market
The global Clotting Factor market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Clotting Factor market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Clotting Factor market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Clotting Factor market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Clotting Factor market.

Global Clotting Factor Scope and Market Size
Clotting Factor market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Clotting Factor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Clotting Factor I
Clotting Factor II
Clotting Factor III
Clotting Factor IV
Others

Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Amgen
Novartis
Baxter
Britannia
Capricor
CSL Behring
GlaxoSmithKline
Grifol
Eli Lilly

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clotting Factor Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Clotting Factor I
1.2.3 Clotting Factor II
1.2.4 Clotting Factor III
1.2.5 Clotting Factor IV
1.2.6 Others
1.3 Market by Application
1.3.1 Global Clotting Factor Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Clotting Factor Market Perspective (2016-2027)
2.2 Clotting Factor Growth Trends by Regions
2.2.1 Clotting Factor Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Clotting Factor Historic Market Share by Regions (2016-2021)
2.2.3 Clotting Factor Forecasted Market Size by Regions (2022-2027)
2.3 Clotting Factor Industry Dynamic
2.3.1 Clotting Factor Market Trends
2.3.2 Clotting Factor Market Drivers
2.3.3 Clotting Factor Market Challenges
2.3.4 Clotting Factor Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Clotting Factor Players by Revenue
3.1.1 Global Top Clotting Factor Players by Revenue (2016-2021)
3.1.2 Global Clotting Factor Revenue Market Share by Players (2016-2021)
3.2 Global Clotting Factor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Clotting Factor Revenue
3.4 Global Clotting Factor Market Concentration Ratio
3.4.1 Global Clotting Factor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clotting Factor Revenue in 2020
3.5 Clotting Factor Key Players Head office and Area Served
3.6 Key Players Clotting Factor Product Solution and Service
3.7 Date of Enter into Clotting Factor Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Clotting Factor Breakdown Data by Type
4.1 Global Clotting Factor Historic Market Size by Type (2016-2021)
4.2 Global Clotting Factor Forecasted Market Size by Type (2022-2027)

5 Clotting Factor Breakdown Data by Application
5.1 Global Clotting Factor Historic Market Size by Application (2016-2021)
5.2 Global Clotting Factor Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Clotting Factor Market Size (2016-2027)
6.2 North America Clotting Factor Market Size by Type
6.2.1 North America Clotting Factor Market Size by Type (2016-2021)
6.2.2 North America Clotting Factor Market Size by Type (2022-2027)
6.2.3 North America Clotting Factor Market Size by Type (2016-2027)
6.3 North America Clotting Factor Market Size by Application
6.3.1 North America Clotting Factor Market Size by Application (2016-2021)
6.3.2 North America Clotting Factor Market Size by Application (2022-2027)
6.3.3 North America Clotting Factor Market Size by Application (2016-2027)
6.4 North America Clotting Factor Market Size by Country
6.4.1 North America Clotting Factor Market Size by Country (2016-2021)
6.4.2 North America Clotting Factor Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Clotting Factor Market Size (2016-2027)
7.2 Europe Clotting Factor Market Size by Type
7.2.1 Europe Clotting Factor Market Size by Type (2016-2021)
7.2.2 Europe Clotting Factor Market Size by Type (2022-2027)
7.2.3 Europe Clotting Factor Market Size by Type (2016-2027)
7.3 Europe Clotting Factor Market Size by Application
7.3.1 Europe Clotting Factor Market Size by Application (2016-2021)
7.3.2 Europe Clotting Factor Market Size by Application (2022-2027)
7.3.3 Europe Clotting Factor Market Size by Application (2016-2027)
7.4 Europe Clotting Factor Market Size by Country
7.4.1 Europe Clotting Factor Market Size by Country (2016-2021)
7.4.2 Europe Clotting Factor Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Clotting Factor Market Size (2016-2027)
8.2 Asia-Pacific Clotting Factor Market Size by Type
8.2.1 Asia-Pacific Clotting Factor Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Clotting Factor Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Clotting Factor Market Size by Type (2016-2027)
8.3 Asia-Pacific Clotting Factor Market Size by Application
8.3.1 Asia-Pacific Clotting Factor Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Clotting Factor Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Clotting Factor Market Size by Application (2016-2027)
8.4 Asia-Pacific Clotting Factor Market Size by Region
8.4.1 Asia-Pacific Clotting Factor Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Clotting Factor Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Clotting Factor Market Size (2016-2027)
9.2 Latin America Clotting Factor Market Size by Type
9.2.1 Latin America Clotting Factor Market Size by Type (2016-2021)
9.2.2 Latin America Clotting Factor Market Size by Type (2022-2027)
9.2.3 Latin America Clotting Factor Market Size by Type (2016-2027)
9.3 Latin America Clotting Factor Market Size by Application
9.3.1 Latin America Clotting Factor Market Size by Application (2016-2021)
9.3.2 Latin America Clotting Factor Market Size by Application (2022-2027)
9.3.3 Latin America Clotting Factor Market Size by Application (2016-2027)
9.4 Latin America Clotting Factor Market Size by Country
9.4.1 Latin America Clotting Factor Market Size by Country (2016-2021)
9.4.2 Latin America Clotting Factor Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Clotting Factor Market Size (2016-2027)
10.2 Middle East & Africa Clotting Factor Market Size by Type
10.2.1 Middle East & Africa Clotting Factor Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Clotting Factor Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Clotting Factor Market Size by Type (2016-2027)
10.3 Middle East & Africa Clotting Factor Market Size by Application
10.3.1 Middle East & Africa Clotting Factor Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Clotting Factor Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Clotting Factor Market Size by Application (2016-2027)
10.4 Middle East & Africa Clotting Factor Market Size by Country
10.4.1 Middle East & Africa Clotting Factor Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Clotting Factor Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Clotting Factor Introduction
11.1.4 Amgen Revenue in Clotting Factor Business (2016-2021)
11.1.5 Amgen Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Clotting Factor Introduction
11.2.4 Novartis Revenue in Clotting Factor Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Baxter
11.3.1 Baxter Company Details
11.3.2 Baxter Business Overview
11.3.3 Baxter Clotting Factor Introduction
11.3.4 Baxter Revenue in Clotting Factor Business (2016-2021)
11.3.5 Baxter Recent Development
11.4 Britannia
11.4.1 Britannia Company Details
11.4.2 Britannia Business Overview
11.4.3 Britannia Clotting Factor Introduction
11.4.4 Britannia Revenue in Clotting Factor Business (2016-2021)
11.4.5 Britannia Recent Development
11.5 Capricor
11.5.1 Capricor Company Details
11.5.2 Capricor Business Overview
11.5.3 Capricor Clotting Factor Introduction
11.5.4 Capricor Revenue in Clotting Factor Business (2016-2021)
11.5.5 Capricor Recent Development
11.6 CSL Behring
11.6.1 CSL Behring Company Details
11.6.2 CSL Behring Business Overview
11.6.3 CSL Behring Clotting Factor Introduction
11.6.4 CSL Behring Revenue in Clotting Factor Business (2016-2021)
11.6.5 CSL Behring Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Clotting Factor Introduction
11.7.4 GlaxoSmithKline Revenue in Clotting Factor Business (2016-2021)
11.7.5 GlaxoSmithKline Recent Development
11.8 Grifol
11.8.1 Grifol Company Details
11.8.2 Grifol Business Overview
11.8.3 Grifol Clotting Factor Introduction
11.8.4 Grifol Revenue in Clotting Factor Business (2016-2021)
11.8.5 Grifol Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Details
11.9.2 Eli Lilly Business Overview
11.9.3 Eli Lilly Clotting Factor Introduction
11.9.4 Eli Lilly Revenue in Clotting Factor Business (2016-2021)
11.9.5 Eli Lilly Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Clotting Factor Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Clotting Factor I
Table 3. Key Players of Clotting Factor II
Table 4. Key Players of Clotting Factor III
Table 5. Key Players of Clotting Factor IV
Table 6. Key Players of Others
Table 7. Global Clotting Factor Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Clotting Factor Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Clotting Factor Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Clotting Factor Market Share by Regions (2016-2021)
Table 11. Global Clotting Factor Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Clotting Factor Market Share by Regions (2022-2027)
Table 13. Clotting Factor Market Trends
Table 14. Clotting Factor Market Drivers
Table 15. Clotting Factor Market Challenges
Table 16. Clotting Factor Market Restraints
Table 17. Global Clotting Factor Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Clotting Factor Market Share by Players (2016-2021)
Table 19. Global Top Clotting Factor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clotting Factor as of 2020)
Table 20. Ranking of Global Top Clotting Factor Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Clotting Factor Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Clotting Factor Product Solution and Service
Table 24. Date of Enter into Clotting Factor Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Clotting Factor Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Clotting Factor Revenue Market Share by Type (2016-2021)
Table 28. Global Clotting Factor Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Clotting Factor Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Clotting Factor Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Clotting Factor Revenue Market Share by Application (2016-2021)
Table 32. Global Clotting Factor Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Clotting Factor Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Clotting Factor Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Clotting Factor Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Clotting Factor Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Clotting Factor Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Clotting Factor Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Clotting Factor Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Clotting Factor Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Clotting Factor Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Clotting Factor Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Clotting Factor Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Clotting Factor Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Clotting Factor Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Clotting Factor Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Clotting Factor Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Clotting Factor Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Clotting Factor Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Clotting Factor Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Clotting Factor Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Clotting Factor Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Clotting Factor Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Clotting Factor Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Clotting Factor Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Clotting Factor Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Clotting Factor Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Clotting Factor Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Clotting Factor Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Clotting Factor Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Clotting Factor Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Clotting Factor Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Clotting Factor Market Size by Country (2022-2027) & (US$ Million)
Table 64. Amgen Company Details
Table 65. Amgen Business Overview
Table 66. Amgen Clotting Factor Product
Table 67. Amgen Revenue in Clotting Factor Business (2016-2021) & (US$ Million)
Table 68. Amgen Recent Development
Table 69. Novartis Company Details
Table 70. Novartis Business Overview
Table 71. Novartis Clotting Factor Product
Table 72. Novartis Revenue in Clotting Factor Business (2016-2021) & (US$ Million)
Table 73. Novartis Recent Development
Table 74. Baxter Company Details
Table 75. Baxter Business Overview
Table 76. Baxter Clotting Factor Product
Table 77. Baxter Revenue in Clotting Factor Business (2016-2021) & (US$ Million)
Table 78. Baxter Recent Development
Table 79. Britannia Company Details
Table 80. Britannia Business Overview
Table 81. Britannia Clotting Factor Product
Table 82. Britannia Revenue in Clotting Factor Business (2016-2021) & (US$ Million)
Table 83. Britannia Recent Development
Table 84. Capricor Company Details
Table 85. Capricor Business Overview
Table 86. Capricor Clotting Factor Product
Table 87. Capricor Revenue in Clotting Factor Business (2016-2021) & (US$ Million)
Table 88. Capricor Recent Development
Table 89. CSL Behring Company Details
Table 90. CSL Behring Business Overview
Table 91. CSL Behring Clotting Factor Product
Table 92. CSL Behring Revenue in Clotting Factor Business (2016-2021) & (US$ Million)
Table 93. CSL Behring Recent Development
Table 94. GlaxoSmithKline Company Details
Table 95. GlaxoSmithKline Business Overview
Table 96. GlaxoSmithKline Clotting Factor Product
Table 97. GlaxoSmithKline Revenue in Clotting Factor Business (2016-2021) & (US$ Million)
Table 98. GlaxoSmithKline Recent Development
Table 99. Grifol Company Details
Table 100. Grifol Business Overview
Table 101. Grifol Revenue in Clotting Factor Business (2016-2021) & (US$ Million)
Table 102. Grifol Recent Development
Table 103. Eli Lilly Company Details
Table 104. Eli Lilly Business Overview
Table 105. Eli Lilly Clotting Factor Product
Table 106. Eli Lilly Revenue in Clotting Factor Business (2016-2021) & (US$ Million)
Table 107. Eli Lilly Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Clotting Factor Market Share by Type: 2020 VS 2027
Figure 2. Clotting Factor I Features
Figure 3. Clotting Factor II Features
Figure 4. Clotting Factor III Features
Figure 5. Clotting Factor IV Features
Figure 6. Others Features
Figure 7. Global Clotting Factor Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Clotting Factor Report Years Considered
Figure 12. Global Clotting Factor Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Clotting Factor Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Clotting Factor Market Share by Regions: 2020 VS 2027
Figure 15. Global Clotting Factor Market Share by Regions (2022-2027)
Figure 16. Global Clotting Factor Market Share by Players in 2020
Figure 17. Global Top Clotting Factor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clotting Factor as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Clotting Factor Revenue in 2020
Figure 19. Global Clotting Factor Revenue Market Share by Type (2016-2021)
Figure 20. Global Clotting Factor Revenue Market Share by Type (2022-2027)
Figure 21. North America Clotting Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Clotting Factor Market Share by Type (2016-2027)
Figure 23. North America Clotting Factor Market Share by Application (2016-2027)
Figure 24. North America Clotting Factor Market Share by Country (2016-2027)
Figure 25. United States Clotting Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Clotting Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Clotting Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Clotting Factor Market Share by Type (2016-2027)
Figure 29. Europe Clotting Factor Market Share by Application (2016-2027)
Figure 30. Europe Clotting Factor Market Share by Country (2016-2027)
Figure 31. Germany Clotting Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Clotting Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Clotting Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Clotting Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Clotting Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Clotting Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Clotting Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Clotting Factor Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Clotting Factor Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Clotting Factor Market Share by Region (2016-2027)
Figure 41. China Clotting Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Clotting Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Clotting Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Clotting Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Clotting Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Clotting Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Clotting Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Clotting Factor Market Share by Type (2016-2027)
Figure 49. Latin America Clotting Factor Market Share by Application (2016-2027)
Figure 50. Latin America Clotting Factor Market Share by Country (2016-2027)
Figure 51. Mexico Clotting Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Clotting Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Clotting Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Clotting Factor Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Clotting Factor Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Clotting Factor Market Share by Country (2016-2027)
Figure 57. Turkey Clotting Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Clotting Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Clotting Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Amgen Revenue Growth Rate in Clotting Factor Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Clotting Factor Business (2016-2021)
Figure 62. Baxter Revenue Growth Rate in Clotting Factor Business (2016-2021)
Figure 63. Britannia Revenue Growth Rate in Clotting Factor Business (2016-2021)
Figure 64. Capricor Revenue Growth Rate in Clotting Factor Business (2016-2021)
Figure 65. CSL Behring Revenue Growth Rate in Clotting Factor Business (2016-2021)
Figure 66. GlaxoSmithKline Revenue Growth Rate in Clotting Factor Business (2016-2021)
Figure 67. Grifol Revenue Growth Rate in Clotting Factor Business (2016-2021)
Figure 68. Eli Lilly Revenue Growth Rate in Clotting Factor Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

以下、関連資料のご紹介

世界の凝固因子市場規模・現状・予測（2021年-2027年）

Global Clotting Factor Market Size, Status and Forecast 2021-2027
QYR2104Z1391 2021年4月 95Pages
QYResearch社発行の本調査資料では、凝固因子のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（凝固因子I、凝固因子II、凝固因子III、凝固因子IV、その他）、用途別市場規模（病院、クリニック、外来手術センター）、主要地域別市場規模（北米...

世界の活性化凝固時間検査市場規模・現状・予測（2021年-2027年）

Global Activated Clotting Time Testing Market Size, Status and Forecast 2021-2027
QYR2104Z0038 2021年4月 92Pages
QYResearch社発行の本調査資料では、活性化凝固時間検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（光学的検出、レーザーベース検出、機械的検出、蛍光ベース検出）、用途別市場規模（病院、臨床検査室、外来手術センター、学術・研究機関、その...

世界の抗血友病因子（AHF）・フォンウィルブランド因子（VWF）複合体市場規模・現状・予測（2021年-2027年）

Global Antihemophilic Factor & von Willebrand Factor Complex Market Size, Status and Forecast 2021-2027
QYR2104Z0392 2021年4月 85Pages
QYResearch社発行の本調査資料では、抗血友病因子（AHF）・フォンウィルブランド因子（VWF）複合体のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（5ml、10ml、15ml）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北...

世界の第IX因子欠乏症治療市場規模・現状・予測（2021年-2027年）

Global Factor IX Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2309 2021年4月 97Pages
QYResearch社発行の本調査資料では、第IX因子欠乏症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（血友病B、血友病B阻害剤）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本...

世界の抗血友病因子（組換え）市場規模・現状・予測（2021年-2027年）

Global Antihemophilic Factor (Recombinant) Market Size, Status and Forecast 2021-2027
QYR2104Z0393 2021年4月 100Pages
QYResearch社発行の本調査資料では、抗血友病因子（組換え）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（250IU、500IU、1000IU、1500IU、2000IU）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、...

世界の抗血管内皮増殖因子（抗VEGF）療法市場規模・現状・予測（2021年-2027年）

Global Anti–vascular Endothelial Growth Factor Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z0421 2021年4月 98Pages
QYResearch社発行の本調査資料では、抗血管内皮増殖因子（抗VEGF）療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抽出注入、プリチャージ注入）、用途別市場規模（黄斑変性症、眼浮腫、ブドウ膜炎、網膜静脈閉塞症）、主要地域別市場規模（...

世界の抗血管内皮増殖因子（抗VEGF）療法市場規模・現状・予測（2021年-2027年）

世界のヒトFGFR3（線維芽細胞成長因子受容体）市場規模・現状・予測（2021年-2027年）

Global Human FGFR3(Fibroblast growth factor receptor) Market Size, Status and Forecast 2021-2027
QYR2104Z2945 2021年4月 90Pages
QYResearch社発行の本調査資料では、ヒトFGFR3（線維芽細胞成長因子受容体）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（Hisタグ、Fcタグ）、用途別市場規模（ELISA、ウエスタンブロット、抗体産生、タンパク質アレイ）、主要地域...

世界のGMP腫瘍壊死因子アルファ市場規模・現状・予測（2021年-2027年）

Global GMP Tumor Necrosis Factor Alpha Market Size, Status and Forecast 2021-2027
QYR2104Z2601 2021年4月 99Pages
QYResearch社発行の本調査資料では、GMP腫瘍壊死因子アルファのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（25μg、50μg、その他）、用途別市場規模（細胞/遺伝子治療、組織工学製品、その他）、主要地域別市場規模（北米、アメリカ、ヨ...

世界のGMP腫瘍壊死因子アルファ市場規模・現状・予測（2021年-2027年）

世界の凝固因子市場規模・現状・予測（2021年-2027年） Coagulation factors are various protein components involved in blood coagulation. Its physiological function is to be activated when blood vessels bleed, stick to platelets and plug leaks in blood vessels. Market Analysis and Insights: Global Clotting Factor Market The global Clotting Factor market …
世界の活性化凝固時間検査市場規模・現状・予測（2021年-2027年） The activated clotting time (ACT) is a test that is used primarily to monitor high doses of unfractionated (standard) heparin therapy. Heparin is a drug that inhibits blood clotting (anticoagulant) and is usually given intravenously (IV) by injection or continuous infusion. High doses of heparin may…
世界の抗血友病因子（AHF）・フォンウィルブランド因子（VWF）複合体市場規模・現状・予測（2021年-2027年） Antihemophilic and von Willebrand factor complex is a combination medicine used to treat or prevent bleeding episodes in people with von Willebrand disease. Antihemophilic and von Willebrand factor complex is also used to treat or prevent bleeding episodes in people with hemophilia A. Market Analysi…
世界の第IX因子欠乏症治療市場規模・現状・予測（2021年-2027年） Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B. In this market study, analysts have estimated the prophylaxis segment to dominate the factor IX deficiency treatment market dur…
世界の抗血友病因子（組換え）市場規模・現状・予測（2021年-2027年） Antihemophilic factor is a naturally occurring protein in the blood that helps blood to clot. Market Analysis and Insights: Global Antihemophilic Factor (Recombinant) Market The global Antihemophilic Factor (Recombinant) market size is projected to reach US$ XX million by 2027, from US$ XX million i…